]>
IRCT20150906023922N2 IRCT 2020-07-29 Esfahan University of Medical Sciences Effect of greater occipital nerve block in treatment of headache Evaluation of the effect of greater occipital nerve block in the treatment of medication overuse headache 2019-10-17 anticipated 60 Complete https://irct.ir/trial/48808 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: A blocked randomization method with randomly permuted blocks sizes 4 was used to assign each patients to an intervention or control group, to guarantee recruitment balance between the 2 groups and avoid possible risk for selection bias. Depending on age and gender, individuals are placed in blocks of four and are placed in one of the intervention and control groups using a table of random numbers. Each “block” has a specified number of randomly ordered treatment assignments. Treatment assignments were put in numbered closed envelopes, which were opened sequentially upon patient admission. 3 Medication overuse headache. Intervention 1: Intervention group: The greater occipital nerve will be blocked bilaterally using 1 ml of 2% lidocaine and 1 ml of triamcinolone 40 mg / ml. Patients in the intervention group will undergo a detoxification process using complete discontinuation of acute migraine medications or analgesics. Intervention 2: Control group: No intervention is performed on patients in the control group. Patients in the control group will undergo a detoxification process using complete discontinuation of acute migraine medications or painkillers. Yes - There is a plan to make this available What will be shared: Major part of information will be available for population When: 12 months after publication To whom: Available for people working in academic institutions Conditions: To conduct similar studies Where to obtain: Fariborz Khorvash How to obtain: The data will send as soon as possible, after receiving the request Comments:
public Fariborz Khorvash
Hezarjarib Ave., Isfahan University of Medical Sciences
Isfahan Iran (Islamic Republic of) 8174673461 +98 31 3650 3584 fkhorvash@med.mui.ac.ir Esfahan University of Medical Sciences scientific Fariborz Khorvash
Hezarjarib Ave., Isfahan University of Medical Sciences
Isfahan Iran (Islamic Republic of) 8174673461 +98 31 3650 3584 fkhorvash@med.mui.ac.ir Esfahan University of Medical Sciences Iran (Islamic Republic of) Adult patients (aged >18 years) Having confirmed diagnosis of medication overuse headache (MOH) Previous diagnosis of a primary headache 18 years no limit Both Psychiatric disorders (e.g. severe depression or schizophrenia) Physical disorders (e.g. malignancy, concomitant heart disease) Pregnant or lactating G44 Other headache syndromes Treatment - Other N/A Intervention group: The greater occipital nerve will be blocked bilaterally using 1 ml of 2% lidocaine and 1 ml of triamcinolone 40 mg / ml. Patients in the intervention group will undergo a detoxification process using complete discontinuation of acute migraine medications or analgesics. Control group: No intervention is performed on patients in the control group. Patients in the control group will undergo a detoxification process using complete discontinuation of acute migraine medications or painkillers. Headache severity. Timepoint: At baseline and after 12 weeks. Method of measurement: Visual analogue scale. Headache frequency. Timepoint: At baseline and after 12 weeks. Method of measurement: Record. Headache duration. Timepoint: At baseline and after 12 weeks. Method of measurement: Record. Esfahan University of Medical Sciences Approved 2020-02-02 Ethics committee of Isfahan University of Medical Sciences Hezarjreeb street Isfahan Isfehan Iran (Islamic Republic of)